Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury
By Jenna M. Ziebell, M. Morganti‐Kossmann. Neurotherapeutics, 2011
683 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology, Neurology
View Paper: https://www.semanticscholar.org/paper/b3d4d7d6c447e656f66bac78e8d3257644d472db
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Neurology
Citations in the corpus
- Inflammation and white matter degeneration persist for years after a single traumatic brain injury. (2013, background): “…(Aihara et al., 1995; Gentleman et al., 2004; Wilson et al., 2004; Maxwell et al., 2006; Nagamoto-Combs et al., 2007) that contribute to the multitude of cytokines associated with post-traumatic inflammatory cascades (for review see Loane and Byrnes, 2010; Ziebell and Morganti-Kossmann, 2010).”
- Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. (2012, neutral): “Unfortunately due to space limitations only a small number of promising anti-inflammatory drug treatments can be detailed in this article, and readers are directed to excellent review articles on other preclinical drug treatment strategies for TBI (Shohami et al., 2011; Simard et al., 2010; Ziebell ”